Content
@
0 reply
0 recast
0 reaction
Molecule
@molecule
The drug development game needs a new playbook—one that prioritizes innovation over profit. It's time we put researchers back in the driver’s seat. Molecule is handing over the keys—giving researchers control over their research. Welcome to the future of scientific funding👇
1 reply
1 recast
4 reactions
Molecule
@molecule
Right now, pharma: ❌ Prioritizes managing diseases over curing them ❌ Spends 25x more on promoting drugs than discovery ❌ Engage in ever-greening to extend patent protection Innovation and progress struggle to thrive when all efforts focus on maintaining control.
1 reply
0 recast
0 reaction
Molecule
@molecule
As for researchers? Securing funding is a constant struggle. They spend up to 40% of their time chasing grants. That’s not innovation, that’s bureaucracy. We need a better way. One that realigns incentives to support researchers and fund innovative science👇
1 reply
0 recast
0 reaction
Molecule
@molecule
With IP-NFTs and IP tokens (IPTs), researchers have a new way to turn intellectual property into an incentive for collaboration and funding. Molecule turns IP into a tradable, shareable asset governed by the people who benefit most from the research.
1 reply
0 recast
0 reaction
Molecule
@molecule
IPTs level the playing field for researchers: 🔹 No need for early patents or startups to fundraise 🔹 Build a community of supporters 🔹 Keep control over your data and decide who gets access 🔹 Enable anyone to fund and benefit from your research
1 reply
0 recast
0 reaction
Molecule
@molecule
How do IP-NFTs work? Think of it this way: IPNFTs own the core IP 🔹 IP can be held by a DAO, project, or researcher 🔹 Tokenized & tradable in liquid markets in the form of IPTs
1 reply
0 recast
0 reaction
Molecule
@molecule
How do IPTs work? 🧠 They are the fungible IP tokens of a project. 🔹 Governance tokens for an IP-NFT 🔹 They govern IP pools: shared sets of IP and R&D data 🔹 Multiple stakeholders can vote and control IP
1 reply
0 recast
0 reaction
